Company: AILIM
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001002910-25-000129
Chunk: 110

Company: Ameren Illinois Co
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 110
---
5:AmerenMissouriAmerenIllinoisAmerenBalance at December 31, 2024$823 (a) $4 (b) $827 (a) Liabilities settled(7)— (7)Accretion27 (c) — 27 (c) Change in estimates1 1 2 Balance at September 30, 2025$844 (a) $5 (b) $849 (a) (a)Balance included $5 million in “Other current liabilities” on the balance sheet as of both September 30, 2025, and December 31, 2024.(b)Included in “Other deferred credits and liabilities” on the balance sheet.(c)Accretion expense attributable to Ameren Missouri was recorded as a decrease to regulatory liabilities.Stock-based CompensationIn the first quarter of 2025, Ameren granted 275,869 performance share units with a grant date fair value of $33 million and 118,213 restricted share units with a grant date fair value of $11 million. Awards vest approximately 3 years after the grant date based on continued employment or on a pro-rata basis upon death or eligible retirement. The performance share units vest based on the achievement of certain specified market performance measures (236,448 performance share units) or clean energy transition targets (39,421 performance share units). The exact number of shares issued pursuant to a performance share unit varies from 0% to 200% of the target award, depending on actual company performance relative to the performance goals.For the nine months ended September 30, 2025 and 2024, excess tax benefits (deficiencies) associated with the settlement of stock-based compensation awards decreased income tax expense by $1 million and increased income tax expense by $1 million, respectively.Deferred CompensationAt September 30, 2025, and December 31, 2024, the present value of benefits to be paid for deferred compensation obligations was $80 million and $79 million, respectively, which was primarily reflected in “Other deferred credits and liabilities” on Ameren’s consolidated balance sheet.Operating RevenuesAs of September 30, 2025 and 2024, our remaining performance obligations for contracts with a term greater than one year were immaterial. The Ameren Companies elected not to disclose the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied as of the end of the